Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease

被引:6
|
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [1 ,2 ,3 ]
Stote, Kim S. [4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] SUNY Empire State Coll, Saratoga Springs, NY 12866 USA
关键词
phosphate; phosphorus; chronic kidney disease; parathyroid hormone; fibroblast growth factor 23; DIETARY PHOSPHORUS RESTRICTION; CHRONIC-RENAL-FAILURE; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; HYPER-PARATHYROIDISM; MINERAL METABOLISM; FGF23; CALCIUM; RATS; CKD;
D O I
10.5414/CN108686
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Increased concentrations of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) often coincide with normal serum phosphorus ([P](s)) in chronic kidney disease (CKD). We hypothesized that the phosphate concentration ([P](f)) in the cortical distal nephron (CDN) determines [PTH] and [FGF23] in this circumstance. Methods: We studied 29 patients with CKD at 4 visits and 28 controls at 1 visit. Assuming GFR = creatinine clearance (C-cr), we examined the following regressions: [P](s) on its determinants, E-P/C-cr and TRP/C-cr (P excretion and reabsorption per volume of filtrate); [PTH] and [FGF23] on [P] s and E-P/C-cr; and TRP/C-cr on [PTH] and [FGF23]. We assumed that E-P/C-cr is proportional to [P](f) in the CDN. Results: In controls, [P](s) correlated with TRP/C-cr but not E-P/C-cr. [PTH] and [FGF23] were unrelated to [P](s), E-P/C-cr, and TRP/C-cr. In CKD, [P](s) correlated with E-P/C-cr and TRP/C-cr. [PTH] correlated with [P](s) at 2 visits and with E-P/C-cr at 4; [FGF23] correlated with [P](s) and E-P/C-cr at all visits. TRP/C-cr correlated with [FGF23] and [PTH] at one visit each. Conclusions: [P](f) in the CDN, not [P](s), determined [PTH] in CKD. Because [FGF23] was consistently associated with only one determinant of [P](s), E-P/C-cr, we infer that [P](f) also determined [FGF23]. In patients with CKD, we speculate that [P](f) in the CDN regulates FGF23 synthesis at that site.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 50 条
  • [41] Correlation linking fibroblast growth factor 23 in circulation (FGF-23) and serum aldosterone levels in different stages of chronic kidney disease
    Dohuim, Amira Hassan Elsaid
    Ghazy, Medhat Abd El Megeid
    Nosair, Nahla Abdel Aziz
    Hussien, Amr Khalifa
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01)
  • [42] Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
    Scialla, Julia J.
    Wolf, Myles
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (05) : 268 - 278
  • [43] Effect of aluminum hydroxide on serum phosphate and fibroblast growth factor 23 concentrations in young adult cats with surgically induced chronic kidney disease
    Beita, Keren G.
    Lourenco, Bianca N.
    Rehagen, Martina
    Schmiedt, Chad W.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2024, 85 (10)
  • [44] Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?
    Lukaszyk, Ewelina
    Lukaszyk, Mateusz
    Koc-Zorawska, Ewa
    Bodzenta-Lukaszyk, Anna
    Malyszko, Jolanta
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (04) : 845 - 850
  • [45] Parathyroid hormone and growth in chronic kidney disease
    Simon Waller
    Pediatric Nephrology, 2011, 26 : 195 - 204
  • [46] Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
    Urena-Torres, Pablo A.
    Vervloet, Marc
    Mazzaferro, Sandro
    Oury, Franck
    Brandenburg, Vincent
    Bover, Jordi
    Cavalier, Etienne
    Cohen-Solal, Martine
    Covic, Adrian
    Drueke, Tilman B.
    Hindie, Elif
    Evenepoel, Pieter
    Frazao, Joao
    Goldsmith, David
    Kazama, Junichiro James
    Cozzolino, Mario
    Massy, Ziad A.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (02) : 269 - 280
  • [47] Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease
    Seiler-Mussler, Sarah
    Limbach, Anne S.
    Emrich, Insa E.
    Pickering, John W.
    Roth, Heinz J.
    Fliser, Danilo
    Heine, Gunnar H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (04): : 569 - 576
  • [48] Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease
    Bover, Jordi
    Arana, Carolt
    Urena, Pablo
    Torres, Armando
    Martin-Malo, Alejandro
    Fayos, Leonor
    Coll, Veronica
    Jesus Lloret, Maria
    Ochoa, Jackson
    Almaden, Yolanda
    Guirado, Lluis
    Rodriguez, Mariano
    NEFROLOGIA, 2021, 41 (05): : 514 - 528
  • [49] High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4
    Tsai, Ming-Hsien
    Leu, Jyh-Gang
    Fang, Yu-Wei
    Liou, Hung-Hsiang
    MEDICINE, 2016, 95 (11)
  • [50] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bielesz, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (7-8) : 194 - 197